FDG—PET/CT在鼻咽癌分期及放射治疗中的研究进展

摘要/Abstract

摘要： <正>鼻咽癌(nasopharyngeal carcinoma,NPC)是起源于上皮组织的恶性肿瘤,高发区分布在我国南方及部分东南亚国家。放射治疗是NPC的主要治疗手段,近来,随着CT、MRI及正电子发射断层扫描(positronemission tomography,PET)等先进影像技术和三维适形放疗(3-dimensional conformal radiotherapy,3DCRT)、调强放射治疗(intensity-modulated radiothera-

关键词: 正电子发射, 临床分期, 鼻咽癌, 放射治疗

于金明;刘宁波;. FDG—PET/CT在鼻咽癌分期及放射治疗中的研究进展[J]. 中国癌症防治杂志, 2009, 1(02): 95-97.

参考文献

1 Chong VF,Ong CK.Nasopharyngeal carcinoma[J].Eur J Radiol,2008,66(3): 437-447. 2于金明.21世纪的放射肿瘤学[J].中华肿瘤杂志,2002,24(6):521-525. 3秦朝军,黄盛才,王仁生,等.~(18)F-FDG PET/CT显像诊断原发鼻咽癌的价值[J].广西医学,2008,4:474-476. 4 Comoretto M,Balestreri L,Borsatti E,et al.Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT[J].Radiology,2008,249 (1):203-211. 5于金明,刘宁波.非小细胞肺癌表皮生长因子受体分子影像研究进展[J].中华肿瘤杂志,2009,2:81-84. 6罗耀武,唐安戊,徐卫平.~(18)F-FDG PET显像诊断原发性鼻咽癌的价值[J].中华核医学,2003 5:271-.274. 7潘衍基,冯彦林,卫光宇.~(18)F-FDG PET显像在鼻咽癌诊断治疗中的价值[J] .中国肿瘤临床,2004,8:444-446. 8 Yen RF,Chen TH,Ting LL,et al.Early restaging whole-body(18) F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma[J].Eur J Nucl Med Mol Imaging, 2005,32(10):1152-59. 9 Lee SW,Nam SY,Im KC,et al.Prediction of prognosis using standardized uptake value of 2-[(18) F]fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinornas[J].Radiother Oncol,2008,87(2):211-216. 10 Yen TC,Chang YC,Chan SC,et al.Are dual-phase ~(18)F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes[J]? Eur J Nucl Med Mol Imaging,2005,32(5):541-548. 11 Chan SC,Chang JT,Wang HM,et al.Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma:the role of standardized uptake value [J].Oral Oncol,2009,45(1):52-58. 12 Chan SC,Ng SH,ChangJ T,et al.Advantages and pitfalls of 18F-fluoro-2-deoxy -D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma:comparison with magnetic resonance imaging [J].EurJ Nucl Med Mol Imaging,2006,33(9):1032-40. 13 Gordin A,Golz A,Daitzchman M,et al.Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx:diagnostic accuracy and impact on clinical management [J].Int J Radiat Oncol Biol Phys,2007,68(2):370-376. 14 Yen TC,Lin CY,Wang HM,et al.~(18)F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma[J].Int J Radiat Oncol Biol Phys, 2006,65(5):1307-14. 15 Chang JT,Chan SC,Yen TC,et al.Nasopharyngeal carcinoma staging by(18) F-fluorodeoxyglucose positron emission tomography[J].Int J Radiat Oncol Biol Phys,2005,62(2):501-507. 16 Ng SH,Chang JT,Chan SC,et al.Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET[J].Eur J Nucl Med Mol Imaging, 2004,31(8):1073-80. 17 King AD,Ma BB,Yau YY,et al.The impact of ~(18)F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis[J].Br J Radiol,2008,81(964): 291-298. 18 Sheng CC,Tzu CY,Shu HN,et al.18-fluoro-2-deoxyglucose positron emission tomograhy in detecting residual/recuurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging[J].Cancer,2003,98:283-287. 19 Liu T,Xu W,Yan WL,et al.FDG-PET,CT,MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma,which one is the best? A systematic review[J].Radiother Oncol,2007,85(3):327-335. 20 Tsai MH,Shiau YC,Kao CH,et al.Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy [J].J Cancer Res Clin Oncol,2002,128(5):279-282. 21 Ling CC,Humm J,Larson S,et al.Towards multidimensional radiotherapy (MD-CRT):biological imaging and biological conformality[J].Int J Radiat Oncol Biol Phys,2000,47:551-560. 22 Zheng XK,Chen LH,Wang QS,et al.Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma [J].Int J Radiat Oncol Biol Phys,2007,69(5):1381-88. 23 Grosu AL,Piert M,Weber WA,et al.Positron emission tomography for radiation treatment planning[J].Strahlenther Onkol,2005,181(8):483-499. 24 Breen SL,PublicoverJ,De-SilvaS,etal.Intraobserver and interobserver varia- bility in GTV delineation on FDG-PET-CT images of head and neck cancers[J]. Int J Radiat Oncol Biol Phys,2007,68(3):763-770. 25 Murakami R,Uozumi H,Hirai T,et al.Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma:intermethod and interobserver variations[J].Acta Radiol,2008,49(6):693-699. 26 Guido A,Fuccio L,Rombi B,et al.Combined ~(18)F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer[J].Int J Radiat Oncol Biol Phys,2009,73(3):759-763. 27 Wang D,Schultz CJ,Jursinic PA,et al.Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma[J].Int J Radiat Oncol Biol Phys, 2006,65(1):143-151. 28 Paulino AC,Koshy M,Howell R,et al.Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer[J].Int J Radiat Oncol Biol Phys,2005,61(5):1385-92. 29 Schinagl DA,Vogel WV,Hoffmann AL,et al.Comparison of five segmentation tools for ~(18)F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer[J].Int J Radiat Oncol Biol Phys, 2007,69(4):1282-89. 30 El-Bassiouni M,Ciernik IF,Davis JB,et al.[~(18)FDG]PET-CT-based intensity -modulated radiotherapy treatment planning of head and neck cancer[J].Int J Radiat Oncol Biol Phys,2007,69(1):286-293.

[1]	中国抗癌协会整合肿瘤学分会, 中国抗癌协会肿瘤标志专业委员会. 非小细胞肺癌放疗联合免疫治疗中国专家共识（2024版）[J]. 中国癌症防治杂志, 2024, 16(5): 505-515.
[2]	王勇, 周玉玲, 周琼辉, 曾彪, 胡英. 3D打印补偿膜在乳腺癌即刻乳房重建术后放疗中的应用[J]. 中国癌症防治杂志, 2024, 16(1): 96-100.
[3]	周玉飞, 李开国, 杨晓慧, 陈旭霞, 陈伟玲, 曲颂. LGR4对鼻咽癌细胞增殖、凋亡、侵袭、迁移及上皮间质转化的影响[J]. 中国癌症防治杂志, 2023, 15(5): 525-532.
[4]	陈旭霞, 杨晓慧, 陈伟玲, 周玉飞, 李开国, 曲颂. 过表达核凋亡诱导因子1增强鼻咽癌细胞放射敏感性[J]. 中国癌症防治杂志, 2023, 15(3): 272-277.
[5]	覃月兰, 孙永楚, 陈凯华, 宋阳光, 刘滢滢, 朱小东. IFIT3对鼻咽癌CNE⁃2R细胞侵袭转移及EMT的影响[J]. 中国癌症防治杂志, 2023, 15(2): 143-148.
[6]	宋阳光, 孙永楚, 覃月兰, 陈凯华, 赖林, 陈锡山, 朱小东. 过表达miR⁃486⁃5p增强鼻咽癌放射抗拒细胞株CNE⁃2R放射敏感性[J]. 中国癌症防治杂志, 2023, 15(1): 11-17.
[7]	黄玉娟, 邓雅言, 刘雪, 陈勇, 黎秋云, 叶家享, 张锦燕, 李永强. EBV⁃miR⁃BART17⁃5p对鼻咽癌细胞增殖及迁移功能的调控及其作用机制[J]. 中国癌症防治杂志, 2023, 15(1): 25-30.
[8]	徐永荣, 杨丽, 麻玲霞, 黄遐, 甘洁梅. 自我表露在鼻咽癌患者述情障碍和恐惧疾病进展中的中介效应分析[J]. 中国癌症防治杂志, 2023, 15(1): 70-74.
[9]	成超, 李杰. 放疗联合免疫检查点抑制剂治疗肺癌致放射⁃免疫相关性肺炎的研究进展[J]. 中国癌症防治杂志, 2022, 14(6): 687-692.
[10]	罗丽华, 张思佳, 向东华, 易俊林. EBV及PD⁃L1在局部晚期鼻咽癌中的研究进展[J]. 中国癌症防治杂志, 2022, 14(4): 463-469.
[11]	邱丽燕, 杨丽. 基于互联网平台的延续管理在鼻咽癌出院5年症状困扰患者中的应用价值[J]. 中国癌症防治杂志, 2022, 14(3): 314-319.
[12]	游冬玲, 龙恩, 路顺, 徐鹏, 王树斌, 郎锦义. 鼻咽癌诱导化疗敏感基因的研究进展[J]. 中国癌症防治杂志, 2022, 14(3): 328-333.
[13]	侯光营, 苗珺珺, 胡建伟, 郜蕾, 张永侠, 袁香坤. 3D打印微创导向模板插植放射治疗联合深部热疗治疗局部晚期宫颈癌的疗效分析[J]. 中国癌症防治杂志, 2022, 14(1): 76-81.
[14]	王梓萌, 向作林 . 立体定向放射治疗肝脏转移瘤的临床疗效[J]. 中国癌症防治杂志, 2021, 13(6): 641-646.
[15]	陈思皓, 张石川, 李厨荣, 吕俭霞. 鼻咽癌临床分型研究进展 [J]. 中国癌症防治杂志, 2021, 13(5): 564-568.